LRP6 and gastric cancer: Nevertheless, by identifying the contributing role of β‐catenin, as well as LRP6 and GSK3β, in M hyorhinis‐induced motility, this study may provide valuable evidence for patient‐directed therapies for M hyorhinis‐positive gastric cancer patients.